Salesforce.com (CRM) Stock Declines While Market Improves: Some Information for Investors

Salesforce.com (CRM) declined 2.57% to $263.97 in its most recent session, underperforming the broader market and lagging its sector over the past month. Despite this recent softness, analysts anticipate strong growth for the software developer, projecting Q1 EPS of $2.77 (+8.2% YoY) and revenue of $10.13 billion (+8.66% YoY), with similar full-year expectations. CRM, currently holding a Zacks Rank #3 (Hold), trades at a Forward P/E of 23.98 and PEG ratio of 1.86, both representing a discount to industry averages within the strong Computer - Software sector.

Analysis

Salesforce.com (CRM) exhibited significant short-term underperformance, closing down 2.57% at $263.97 on a day when major indices posted gains. This recent weakness extends over the past month, with the stock's 1.88% rise lagging both the S&P 500's 4.37% gain and its own Computer and Technology sector's 6.2% increase. Despite this negative price momentum, forward-looking fundamentals appear robust. Analyst consensus projects the company will report 8.2% year-over-year EPS growth to $2.77 and 8.66% revenue growth to $10.13 billion in its upcoming earnings release. The full-year outlook is similarly positive, with estimates pointing to a 10.78% increase in earnings and 8.64% in revenue. However, a minor note of caution is warranted as the consensus EPS projection has edged 0.04% lower over the last 30 days, contributing to its current Zacks Rank of #3 (Hold). From a valuation perspective, CRM appears attractive relative to its peers, trading at a Forward P/E of 23.98, below the industry average of 27.42, and a PEG ratio of 1.86, which is also below the industry's 2.4 average. This suggests a potential valuation discount within a highly-ranked industry, as the Computer - Software sector sits in the top 15% of all industries tracked by Zacks.

Key Decisions for Investors

• Investors should closely scrutinize the upcoming earnings report to validate if the company can meet the consensus revenue growth of 8.66% and EPS growth of 8.2%, as this will be a key catalyst to reverse the recent stock underperformance.
• The stock's valuation, with a Forward P/E of 23.98 and a PEG ratio of 1.86, represents a notable discount to its industry average, suggesting a potential entry point for value-oriented growth investors if fundamental strength is confirmed.
• Given the slight downward revision in EPS estimates and the stock's lagging performance, it is prudent to monitor for any weakness in forward guidance, as a failure to reaffirm the strong full-year outlook could trigger further downside.